---
$id: https://graph.org.ai/products/commodity/51361919
$type: Product
source: UNSPSC
code: "51361919"
title: "Proxibarbal or proxibarbital"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Proxibarbal or proxibarbital

**UNSPSC Code**: 51361919
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a sedative and hypnotic with the molecular formula C10H14N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F97OMS297F, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(2-hydroxypropyl)-5-(2-propenyl)-, (+-)- (9ci) but generally known as proxibarbal, which bears US NIH Compound Identifier 17336. European Medicines Agency schedules Proxibarbal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10147MIG. The term PROXIBARBAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules proxibarbal in its Anatomical Therapeutic Chemical (ATC) Classification. PROXIBARBAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Proxibarbal or proxibarbital bears US NLM identifiers UMLS ID C0288495 and NCI Concept Code C74375. SMILES: CC(CC1(C(=O)NC(=O)NC1=O)CC=C)O.

